Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2019 | Story Xolisa Mnukwa | Photo Barend Nagel
Prof Puleng LenkaBula
“I want to establish a paradigm shift from community engagement to engaged scholarship, which will transfer science between communities and form reciprocal collaborations in order to create new knowledge, research niche areas, influences, and support systems to aid innovative and progressive teaching and learning processes at the UFS.” – Prof LenkaBula

The University of the Free State (UFS) Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, Prof Puleng LenkaBula, recently visited the Fulda University of Applied Sciences in Germany to discuss a possible future collaboration between the two institutions.

This was inspired by their multidisciplinary approach to higher-education courses, which she aims to facilitate at the UFS in order to pioneer critical thinking among students to ultimately bring about effective and innovative societal problem-solving in South Africa.

Fulda University is an exceptional higher-education institution with the ability to develop and transform itself to purposefully improve its infrastructure, the quality of students, and studies offered by the university. Their different degrees are structured to intersect with the requirements of the progressive European economic environment.

According to Prof LenkaBula, Fulda University is an outstanding institution specialising in applied sciences and theoretical studies, which set them apart from other universities in the advanced European higher-education system.

Prof LenkaBula believes that the prospect of developing joint master’s and/or doctoral degrees between the UFS and Fulda University would expose UFS students to high-quality international higher-education systems. This will ensure that our students are provided with essential skills to become globally competitive and relevant in their designated career fields, and to become strong contenders in an environment characterised by globalisation and the 4th Industrial Revolution (4IR).
She referred to the global exchange of knowledge systems between the UFS and Fulda University as an opportunity for the UFS to improve the university’s global rankings through learning and participating in international collaborative approaches in higher education. 

“In order for our university to cease being seen as an ivory tower, it must be involved in producing knowledge that is beneficial to socio-economic and political development – not only for South Africa, but also for the rest of the world,” said Prof LenkaBula.


News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept